ROZLYTREK Financial resources

Financial and Other Resources

Learn more about financial and other resources for ROZLYTREK

Testing for NTRK fusion-positive solid tumors and ROS1+ mNSCLC

Testing Is the Only Way

to identify appropriate patients for ROZLYTREK. Find out how to test your patients. 1,2 

mNSCLC=metastatic non-small cell lung cancer; MOA=mechanism of action; NTRK=neurotrophic tyrosine receptor kinase; ROS1=ROS proto-oncogene 1.